Advocacy intelligence hub — real-time data for patient organizations
Kcentra: FDA approved
Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or need for an urgent surgery/invasive procedure.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Kcentra
CSL Behring
Browse all Disorder of vitamin and non-protein cofactor absorption and transport news →
View all Disorder of vitamin and non-protein cofactor absorption and transport specialists →